LOOMIS SAYLES & CO L P

Holdings History for BIOMARIN PHARMACEUTICAL INC - NOTE 1.500%10/1

Investment type: Debt / NOTE 1.500%10/1

Holdings date	Change	Value $	Principal	Price	All Holders
31 Mar 2020	0%	$2,287,000	27,063	8450.65% ^*	Q1 2020
31 Dec 2019	0%	$2,288,000	27,063	8454.35% ^*	Q4 2019
30 Sep 2019	0%	$3,637,000	53,966	6739.43% ^*	Q3 2019
30 Jun 2019	0%	$5,703,000	54,030	10555.25% ^*	Q2 2019
31 Mar 2019	0%	$5,838,000	54,561	10699.95% ^*	Q1 2019
31 Dec 2018	0%	$4,709,000	55,305	8514.6% ^*	Q4 2018
30 Sep 2018	0%	$31,435,000	278,331	11294.11% ^*	Q3 2018
30 Jun 2018	0%	$36,216,000	324,714	11153.2% ^*	Q2 2018
31 Mar 2018	0%	$34,843,000	336,057	10368.18% ^*	Q1 2018
31 Dec 2017	0%	$47,396,000	425,033	11151.13% ^*	Q4 2017
30 Sep 2017	0%	$72,341,000	641,972	11268.56% ^*	Q3 2017
30 Jun 2017	0%	$33,315,000	366,828	9081.91% ^*	Q2 2017
31 Mar 2017	0%	$32,900,000	374,805	8777.9% ^*	Q1 2017
31 Dec 2016	0%	$51,661,000	468,229	11033.28% ^*	Q4 2016
30 Sep 2016	0%	$47,201,000	510,162	9252.16% ^*	Q3 2016
30 Jun 2016	0%	$46,025,000	591,575	7780.08% ^*	Q2 2016
31 Mar 2016	0%	$49,467,000	599,742	8248.05% ^*	Q1 2016
31 Dec 2015	0%	$64,059,000	611,479	10476.08% ^*	Q4 2015
30 Sep 2015	0%	$50,323,000	477,810	10532.01% ^*	Q3 2015
30 Jun 2015	0%	$49,800,000	364,087	13678.05% ^*	Q2 2015
31 Mar 2015	0%	$36,128,000	289,909	12461.84% ^*	Q1 2015
31 Dec 2014	0%	$26,215,000	289,994	9039.84% ^*	Q4 2014
30 Sep 2014	0%	$21,186,000	293,605	7215.82% ^*	Q3 2014
30 Jun 2014	0%	$15,930,000	256,069	6220.98% ^*	Q2 2014
31 Mar 2014	0%	$9,135,000	133,924	6821.03% ^*	Q1 2014
31 Dec 2013	0%	$9,417,000	133,860	7034.96% ^*	Q4 2013

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.